Purple Biotech (PPBT) Gains from Investment Securities (2017 - 2021)
Purple Biotech (PPBT) reported Gains from Investment Securities of -$34000.0 for Q4 2021, up 99.58% year-over-year from -$17036.0 in Q4 2020, and up 27.66% quarter-over-quarter from -$47000.0 in Q3 2021.
Purple Biotech (PPBT) Gains from Investment Securities (2017 - 2021) Analysis & Trends
Purple Biotech (PPBT) has 5 years of Gains from Investment Securities data on file, last reported at -$34000.0 in Q4 2021.
- Gains from Investment Securities for Q4 2021 came in at -$34000.0, up 99.58% year-over-year; the trailing twelve-month figure through Dec 2021 was -$155000.0 (up 98.54% YoY), and the FY2021 annual result was -$108000.0, down 100.7% from the prior year.
- Gains from Investment Securities advanced to -$34000.0 in Q4 2021 per PPBT's latest filing, from -$47000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $1.0 million in Q4 2017 and troughed at -$8.1 million in Q4 2020.
- A 5-year average of -$1.3 million and a median of -$72500.0 in 2021 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2020 and 2021: Gains from Investment Securities sank 1442.53% in 2020, then surged 99.58% in 2021.
- A 5-year view of Gains from Investment Securities shows it stood at $1.0 million in 2017, then slumped by 406.08% to -$3.1 million in 2018, then soared by 83.0% to -$522000.0 in 2019, then slumped by 1442.53% to -$8.1 million in 2020, then surged by 99.58% to -$34000.0 in 2021.
- Business Quant data shows PPBT's Gains from Investment Securities at -$34000.0 in Q4 2021, -$47000.0 in Q3 2021, and $24000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -34,000.00 |
| Dec 31, 2021 | -34,000.00 |
| Sep 30, 2021 | -47,000.00 |
| Sep 30, 2021 | -47,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | -98,000.00 |
| Mar 31, 2021 | -98,000.00 |
| Dec 31, 2020 | -8.05 Mn |
| Dec 31, 2020 | -8.05 Mn |
| Dec 31, 2019 | -522,000.00 |
| Dec 31, 2019 | -522,000.00 |
| Dec 31, 2018 | -3.07 Mn |
| Dec 31, 2018 | -3.07 Mn |
| Dec 31, 2017 | 1.00 Mn |
| Dec 31, 2017 | 1.00 Mn |